We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia’s TGA Issues Guidance for Devicemakers on Self-Test IVDs
Australia’s TGA Issues Guidance for Devicemakers on Self-Test IVDs
Australia’s Therapeutic Goods Administration (TGA) has outlined its expectations for developers of in vitro diagnostic (IVD) self-tests for infectious diseases like influenza, hepatitis B and hepatitis C, chlamydia, gonorrhea and syphilis.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor